Featured

24 January 2024

ACCORD: new guideline to support consistent and complete reporting of consensus methods in biomedical research

Oxford PharmaGenesis has contributed to the development of the new ACCORD reporting guideline to help the medical and scientific communities to improve the reporting of research involving consensus methodologies. The guideline was published in the non-profit open access journal PLOS Medicine.

All
  • All
  • News
  • Articles
  • Events

First virtual Chartered Institute of Editing and Proofreading conference: a real success

Earlier this month, six Oxford PharmaGenesis editors attended sessions of the online Chartered Institute of Editing and Proofreading (CIEP) conference. A range of topics were presented, including use of macros in editing, style sheets, digital marketing and inclusive language. Some of the presentations provided essential ‘nuts and bolts’ information, while others took a more in-depth…

Continue reading

World Orphan Drug Congress Europe: how to make 'rare' a bit more well done!

The Oxford PharmaGenesis Patient Engagement Team was lucky enough to attend the World Orphan Drug Congress Europe earlier in November. The virtual conference provided invaluable insights into hot topics and current issues for rare diseases. Of much interest to our team were patient centricity, initiatives working with patient groups/advocates and, specifically, discussions around access and…

Continue reading

Oxford PharmaGenesis supports CISCRP's Patient Diversity Campaign

Oxford PharmaGenesis is proud to support CISCRP in a new educational initiative to increase awareness and understanding of clinical research among minority urban communities. We have collaborated with CISCRP to sponsor an advertisement that highlights the key importance of diversity among participants in clinical studies in order to discover treatments that are effective for everyone….

Continue reading

Highlights from World Pharma Pricing Market Access & Evidence Congress 2020

The annual World Pharma Pricing Market Access & Evidence congress was held on 23–25 September 2020 for the first time in a virtual environment, and was attended by members of our Value Demonstration Practice.

Continue reading

World Mental Health Day 2020

Mental health for all. Greater investment – greater access. Everyone, everywhere. Oxford PharmaGenesis is committed to ensuring good mental health and well-being for all of its employees, offering access to support services, training and other valuable resources. We also host a team of trained Mental Health First Aiders (MHFAs) who serve as a point of…

Continue reading

Putting the patient first: Pharma & Patient Europe 2020

Oxford PharmaGenesis was delighted to attend the recent eyeforpharma Patient Summit 2020 earlier this month. As part of the ‘new normal’, the meeting this year was virtual, and content was available on demand. This allowed multiple members of the Patient Engagement Team to attend and gain insights on the latest in the patient engagement field….

Continue reading